Department of Anti-Doping Research, Institute of Sport, Warsaw, Poland.
Int J Sports Med. 2009 Aug;30(8):569-72. doi: 10.1055/s-0029-1202826. Epub 2009 Apr 20.
Pseudoephedrine (PSE) as a sympathomimetic is an ingredient of many proprietary medicines which are available on the medical market over the counter (OTC drugs). It can be converted to cathine (CATH, norpseudoephedrine) inside the body. Until the end of 2003, PSE had been a banned substance in sport in case its urinary concentration was greater than 25 mircog/ml. Then the World Anti-Doping Agency (WADA) removed PSE from the prohibited list. Prior to 2004 CATH was a forbidden substance and it is still one. CATH is included on the WADA prohibited list in the group of stimulants. The results of a doping control concerning PSE conducted in the Department of Anti-Doping Research of Institute of Sport in Warsaw in the years 2001-2003 and 2004-2007 have been compared. Moreover, several dozen of urine samples collected from the patients taking OTC drugs with PSE have been analysed. In these samples the concentration of PSE and CATH has been estimated. The results of this study have shown that athletes were using PSE frequently and in high doses between 2004 and 2007 when this substance was permitted by WADA. It is possible that athletes can obtain a positive result of doping control with CATH after the use of PSE.
伪麻黄碱(PSE)作为一种拟交感神经药物,是许多在医疗市场上非处方(OTC 药物)药品的成分。它可以在体内转化为去甲伪麻黄碱(CATH,即去甲麻黄碱)。直到 2003 年底,PSE 一直是运动中的禁用物质,因为其尿样浓度大于 25 微克/毫升。随后,世界反兴奋剂机构(WADA)将 PSE 从禁用名单中删除。在 2004 年之前,CATH 是一种禁用物质,现在仍然是。CATH 被列入 WADA 兴奋剂类别禁用清单。本文对 2001-2003 年和 2004-2007 年在华沙体育学院反兴奋剂研究部进行的 PSE 兴奋剂检测结果进行了比较,此外还对几十份来自服用含 PSE 的 OTC 药物的患者的尿样进行了分析。在这些样本中,对 PSE 和 CATH 的浓度进行了估计。该研究结果表明,在 2004 年至 2007 年 WADA 允许使用 PSE 期间,运动员经常且大量使用 PSE。运动员在使用 PSE 后,可能会导致 CATH 检测呈阳性。